Hudson Bay Capital Management »

Travere Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.7M 125k 13.99
2024-06-30 $366k 45k 8.22
2023-06-30 $6.8M 444k 15.36

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices Put Option (AMD)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Alphabet Cap Stk Cl C Put Option (GOOG)
Broadcom Call Option (AVGO)
New York Cmnty Bancorp Com New (NYCB)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Coinbase Global Com Cl A Put Option (COIN)
Dollar Tree Put Option (DLTR)

View all positions for Hudson Bay Capital Management

Top funds holding Travere Therapeutics

BlackRock
BlackRock
Armistice Capital
Deep Track Capital
Vanguard Group
Rock Springs Capital Management
Macquarie Group
Woodline Partners
State Street Corporation
Morgan Stanley
Kynam Capital Management
Emerald Advisers
Renaissance Technologies
D. E. Shaw & Co
Bank of America Corporation

View all funds holding Travere Therapeutics